Infinium Pharmachem Ltd
Past performance
About Infinium Pharmachem Ltd Infinium Pharmachem Limited, initially incorporated in 2003 and converted to a public entity in 2022, is a globally recognized pharmaceutical and healthcare company based in Gujarat, India. Specializing in the manufacturing and supply of iodine, iodine derivatives, and active pharmaceutical ingredients (APIs), the company is known for its Contract Research and Manufacturing Services (CRAMS) focused on iodine chemistry. Infinium Pharmachem caters to diverse industries, including pharmaceuticals, biotech, specialty chemicals, agrochemicals, and electronics, offering over 200 intermediates and seven APIs.
In 2019, Infinium expanded its global footprint through a joint venture with Shanghai Witofly Chemical Co. Ltd., forming Shanghai Tajilin Industrial Co. Ltd. in China. The company further diversified by establishing Infinium Green Energy Private Limited in 2022. Infinium Pharmachem is preparing for a public issue of up to 1,875,000 equity shares to support its growth and expansion objectives.
Performance overview